SURENA MATIN to Hemangioblastoma
This is a "connection" page, showing publications SURENA MATIN has written about Hemangioblastoma.
Connection Strength
0.097
-
Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. Ann Oncol. 2011 Dec; 22(12):2661-2666.
Score: 0.097
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.